#$%^&*AU2013201492A120131003.pdf#####ABSTRACT The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising 5 administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant.